EDGAR Filing Documents for 0001564590-17-009386

Form 8-K - Current report:

SEC Accession No. 0001564590-17-009386

Filing Date

2017-05-08

Accepted

2017-05-08 16:11:03

Documents

Period of Report

2017-05-08

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	aimt-8k_20170508.htm	8-K	29423
2	EX-99.1	aimt-ex991_6.htm	EX-99.1	170103
3	GRAPHIC	g201705081902355364970.jpg	GRAPHIC	8124
	Complete submission text file	0001564590-17-009386.txt		212098

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884

Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220

Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37519 | Film No.: 17822321
SIC: 2834 Pharmaceutical Preparations